Impetigo
☆ I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha.
Cás impetigo ar an smig. Ba chóir go mbeadh amhras ar impetigo mura bhfuil aon stair gortaithe ag leanbh beag, ach go bhfuil loit atá cosúil le créachta ag scaipeadh.
Murab ionann agus dheirmitíteas atópach, teastaíonn cóireáil antaibheathach ar impetigo agus d’fhéadfadh sé dul in olcas le húsáid stéaróidigh.
References
Impetigo is the most common bacterial skin infection in children two to five years of age. There are two principal types: nonbullous (70% of cases) and bullous (30% of cases). Nonbullous impetigo, or impetigo contagiosa, is caused by Staphylococcus aureus or Streptococcus pyogenes, and is characterized by honey-colored crusts on the face and extremities. Impetigo primarily affects the skin or secondarily infects insect bites, eczema, or herpetic lesions. Bullous impetigo, which is caused exclusively by S. aureus, results in large, flaccid bullae and is more likely to affect intertriginous areas. Both types usually resolve within two to three weeks without scarring, and complications are rare, with the most serious being poststreptococcal glomerulonephritis. Treatment includes topical antibiotics such as mupirocin, retapamulin, and fusidic acid. Oral antibiotic therapy can be used for impetigo with large bullae or when topical therapy is impractical. Amoxicillin/clavulanate, dicloxacillin, cephalexin, clindamycin, doxycycline, minocycline, trimethoprim/sulfamethoxazole, and macrolides are options, but penicillin is not. Topical disinfectants are inferior to antibiotics and should not be used. Empiric treatment considerations have changed with the increasing prevalence of antibiotic-resistant bacteria, with methicillin-resistant S. aureus, macrolide-resistant streptococcus, and mupirocin-resistant streptococcus all documented. Fusidic acid, mupirocin, and retapamulin cover methicillin-susceptible S. aureus and streptococcal infections. Clindamycin proves helpful in suspected methicillin-resistant S. aureus infections. Trimethoprim/sulfamethoxazole covers methicillin-resistant S. aureus infection, but is inadequate for streptococcal infection.
Ionfhabhtú craiceann coitianta is ea Impetigo de bharr baictéir áirithe, a scaiptear go héasca trí theagmháil. De ghnáth taispeánann sé suas mar phaistí dearga clúdaithe le screamh buí agus féadann sé tochas nó pian a chur faoi deara. Tá an ionfhabhtú seo is coitianta i leanaí atá ina gcónaí i gceantair te, tais. Is féidir le feiceáil mar blisters nó gan iad. Cé go gcuireann sé isteach ar an duine go minic, is féidir leis tarlú áit ar bith ina bhfuil briseadh sa chraiceann. Braitheann diagnóis go príomha ar na hairíonna agus ar an gcuma atá air. Cuimsíonn cóireáil de ghnáth antaibheathaigh, ó bhéal agus ó bhéal, chomh maith le bainistiú siomptóm.
Impetigo is a common infection of the superficial layers of the epidermis that is highly contagious and most commonly caused by gram-positive bacteria. It most commonly presents as erythematous plaques with a yellow crust and may be itchy or painful. The lesions are highly contagious and spread easily. Impetigo is a disease of children who reside in hot humid climates. The infection may be bullous or nonbullous. The infection typically affects the face but can also occur in any other part of the body that has an abrasion, laceration, insect bite or other trauma. Diagnosis is typically based on the symptoms and clinical manifestations alone. Treatment involves topical and oral antibiotics and symptomatic care.
Impetigo is a common infection of the superficial layers of the epidermis that is highly contagious and most commonly caused by gram-positive bacteria. It most commonly presents as erythematous plaques with a yellow crust and may be itchy or painful. The lesions are highly contagious and spread easily. Impetigo is a disease of children who reside in hot humid climates. The infection may be bullous or nonbullous. The infection typically affects the face but can also occur in any other part of the body that has an abrasion, laceration, insect bite or other trauma. Diagnosis is typically based on the symptoms and clinical manifestations alone. Treatment involves topical and oral antibiotics and symptomatic care.
Impetigo de ghnáth de bharr Staphylococcus aureus nó Streptococcus pyogenes. Le teagmháil is féidir leis scaipeadh timpeall nó idir daoine. I gcás leanaí, tá sé tógálach dá siblíní.
Go hiondúil déantar cóireáil le huachtair antaibheathach mar mupirocin nó aigéad fusidic. Féadfar antaibheathaigh ó bhéal, mar shampla cefalexin, a úsáid má dhéantar difear do limistéir mhóra.
Chuir impetigo isteach ar thart ar 140 milliún duine (2% de dhaonra an domhain) in 2010. Is féidir leis tarlú ag aois ar bith, ach is coitianta é i leanaí óga. D’fhéadfadh go n-áireofaí deacrachtaí cellulitis nó glomerulonephritis poststreptococcal.
○ Cóireáil - Drugaí thar an gcuntar
* Toisc gur galar tógálach é impetigo, níor cheart ointments steroid a úsáid. Má tá deacracht agat loit impetigo a idirdhealú ó eczemas, le do thoil a ghlacadh frithhistamíní thar an gcuntar gan úsáid a bhaint as ointments steroid.
#OTC antihistamine
* Cuir ointment antaibheathach thar an gcuntar ar an lot le do thoil.
#Bacitracin
#Polysporin